Navigation Links
SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008
Date:10/28/2008

DUBLIN, Calif., Oct. 28 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2008 third quarter financial results on Tuesday, November 4, 2008. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.

A press release will be transmitted to the news media immediately following the close of the market on November 4th. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing 1-888-286-8010 (domestic) and 1-617-801-6888 (international); replay passcode number is 37633541. The webcast replay and conference call replay will be available for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen Inc. is a pharmaceutical company dedicated to the discovery and development of novel cancer therapies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

Contacts:

SuperGen, Inc.

Timothy L. Enns

SVP, Corporate Communications & Business Development

Tel: (925) 560-0100

Email: '/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
2. SuperGen to Present Data at EORTC-NCI-AACR
3. SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008
4. SuperGen Reports 2008 Second Quarter Financial Results
5. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
6. SuperGen Reports 2008 First Quarter Financial Results
7. SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008
8. SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008
9. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
10. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
11. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Sigma-Aldrich Corporatio...Q OMX conference on Tuesday, December 1st at 1:45 ...es may listen via live audio broadcast over the In...a a ldrich.com/ . Users can click the "Webcast...Aldrich: Sigma-Aldrich is a leading Life Science...
(Date:11/24/2009)... Nov. 24 NeurogesX, Inc....used on developing and commercializing novel pain ... DiTonno, President and Chief Executive Officer, i...ffray Health Care Conference, to be held December ..., New York. ,, Mr. DiTonno and Stephen Ghiglie...
(Date:11/24/2009)... endpoint has been met for patients with advanced-...QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEte..."Company"), a global biopharmaceutical company foc...unced positive efficacy data from a Phase 2 study ...S-108 (formerly AN-152), in patients with advanced...
(Date:11/24/2009)..., Nov. 24 Genomic Health... Scott, Genomic Health,s Executive Chairman, will ...re Conference in New York City on Tuesday, Decembe...ive and subsequently archived webcast of the prese...enomic Health,s website at http://investor.genomi...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...s Technologies, Inc. (CTi), a professional consult... Science Applications International Corporation (N...th the National Institute of Allergy and Infectiou...ealth (NIH). The contract to SAIC is for $19 mill...will provide regulatory affairs, technical and adm...
...based company has,successfully grown the first Low...gnificantly lower levels of harmful radioactive ca...hildren nourished with safer, low radiocarbon,Life...r genetic damage events,over their lifetime. By re...efects may also be reduced. Since genetic damage m...
...otech, Inc.,(Nasdaq: OSTE ), a leader in the eme...healing, announced today that its Board of Directo... which up to $5.0 million of,Osteotech,s common st...cuted,from time to time at current market prices t...ctions in such amounts as management deems appropr...
Other Biology Technology:Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health 2World's First Low Radiocarbon Food May Reduce Risks of Cancer and Birth Defects, and Possibly Even Slow the Aging Process 2Osteotech Announces Stock Repurchase Program 2
(Date:11/26/2009)...09) Whitehead researchers have developed a new ty...pecific genes and proteins used by pathogens, acco...an cell cultures genes are present in two copies: ...her. Gene inactivation by mutation is therefore in...e second copy usually remains active and takes ove...
(Date:11/25/2009)...easy lives. In addition to mammalian immune system... called bacteriophages, viruses that kill half the...teria and another class of microorganisms called a...uch as deep-sea volcanic vents) manage just fine, ...fense system that helps protect them from many vir...
(Date:11/25/2009)...nt professors recently received funding from the N...rch beneficial to understanding the environment. T...ackwood, assistant professor in the Department of ... two separate research projects. , His first pro...ties and Functions from the Leaf to the Landscape,...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 1Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 2Radiation Plus Chemo a Good Option in Lung Cancer 52797 1Radiation Plus Chemo a Good Option in Lung Cancer 52797 2Genetic testing may be valuable in treating colorectal cancer 52793 1Genetic testing may be valuable in treating colorectal cancer 52793 2
...WASHINGTONThe science and technology policymaking ...at the next president can better address key issue..., to national security, and the ability of the Uni...lly. The report,s primary recommendations are that...nally respected leader to be Assistant for Science...
...Washington, DC, June 13, 2008 Mary Tyler Moore, t...tional chairman, and her husband, S. Robert Levine...Clinical Research Award" to a team of Florida scie...gton, DC. , The recipients of this year,s prestig...he JDRF Gene Therapy Center for Diabetes and Diabe...
... This release is available in German . , Beca...ndling it, tetrachloromethane (carbon tetrachlorid... countries. However, the processes used in the pro... chloroform (trichloromethane, CHCl3), also produc... rid of this unwanted substance? A team headed by ...
Other Biology News:White House science office needs upgrade 2White House science office needs upgrade 3Florida researchers receive JDRF 'Excellence in Clinical Research Award' 2Fair trade 2
Rabbit Anti-Human Q86TS7 Polyclonal Antibody, Unconjugated from Atlas Antibodies
...ontains 4 deuterium atoms at the 9, 10, 12, and 13...standard for the quantification of 9(S)-HODE by GC...y the lipoxygenation of linoleic acid in both plan...rotic plaques, as an esterified component of membr...
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Biology Products: